Plaque Psoriasis
Symptoms, Doctors, Treatments, Advances & More

Plaque Psoriasis Overview

Save information for later
Sign Up

Learn About Plaque Psoriasis

What is the definition of Plaque Psoriasis?
Plaque psoriasis is the most common form of psoriasis. Psoriasis is an autoimmune skin disorder that affects the growth rate of skin cells. Plaque psoriasis causes raised, reddened dry skin patches with silvery scales that appear on the scalp, elbows, knees, trunk and back.
What are the symptoms of Plaque Psoriasis?
Plaque psoriasis appears in cycles, with periods of remission followed by flare-ups that can last from weeks to months. Symptoms of plaque psoriasis during flare-ups can include reddened, dry skin patches covered in thick silvery scales, usually on the elbows, arms, knees, abdomen, and back, that may cause itching, burning, or bleeding. The sizes of the psoriasis plaques can range from small spots to covering large areas of the body. Nearly half of patients with psoriasis also have abnormal, thickened nails that are pitted or ridged. Psoriasis can also affect the mouth or genitals.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Plaque Psoriasis?
There is currently no cure for plaque psoriasis. Treatments for plaque psoriasis include topical therapy, such as corticosteroids, Vitamin D analogues, retinoids, calcineurin inhibitors, salicylic acid, coal tar, Goeckerman therapy, and anthralin; light therapy; other oral or injected medications; biologics; and alternative therapies.
Who are the top Plaque Psoriasis Local Doctors?
Elite in Plaque Psoriasis
Dr. Bruce Strober
Dermatology
Elite in Plaque Psoriasis
Dr. Bruce Strober
Dermatology
Referral required

Central Connecticut Dermatology PLLC

1 Willowbrook Rd Ste 2, 
Cromwell, CT 
860-322-2222
Languages Spoken:
English
See accepted insurances

Bruce Strober is a Dermatologist practicing medicine in Cromwell, Connecticut. Dr. Strober is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Plaque Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).

Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology
Elite in Plaque Psoriasis
Dr. Andrew Blauvelt
Dermatology
Referral may be required

James W. Baker MD LLC

9495 SW Locust St Ste A, 
Portland, OR 
503-445-2200
Languages Spoken:
English
See accepted insurances

Andrew Blauvelt is a Dermatologist practicing medicine in Portland, Oregon. Dr. Blauvelt is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Atopic Dermatitis, and Actinic Keratosis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Plaque Psoriasis
Dr. Jeffrey J. Crowley
Dermatology
Elite in Plaque Psoriasis
Dr. Jeffrey J. Crowley
Dermatology
Referral may be required

Jeffrey J. Crowley, M.D., Inc.

5101 Commerce Dr, Ste 101, 
Bakersfield, CA 
661-327-3756
Languages Spoken:
English
See accepted insurances
Accepting New Patients

We are dedicated to providing the best care possible for your skin. We specialize in treating and preventing skin cancer. Additionally, we maintain a busy clinical trial program focusing on psoriasis, atopic dermatitis, and hidradenitis suppurativa. Dr. Crowley is rated as an Elite provider by MediFind in the treatment of Plaque Psoriasis. He is also highly rated in 91 other conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Actinic Keratosis, and Seborrheic Keratosis. Dr. Crowley is board certified in Dermatology. Dr. Crowley is currently accepting new patients.

View All Doctors
What are the latest Plaque Psoriasis Clinical Trials?
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis
Enrollment Status: Recruiting
Publish Date: June 18, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3

Summary: The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Zasocitinib in Pediatric Participants Aged 4 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Zasocitinib in Pediatric Participants Aged 4 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Recruiting
Publish Date: June 17, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: The main aim of this study is to see how well the medicine zasocitinib works, how safe it is, and how children and teenagers aged 4 to under 18 with moderate-to-severe plaque psoriasis respond to it. The study will be done in 2 parts: Part A will include both children and teenagers, while part B will only include children. At first, only teenagers who meet the study rules can participate in this s...

View All Clinical Trials